At a glance
ClinicalIndex Comparison RecordN/ACompleted· 63 enrolled
Drug / intervention
HairMax LaserComb 2009 model 12 beam +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind Clinical Trial to Evaluate the Safety and Efficacy of the HairMax LaserComb 2009, 12 Beam Model For The Treatment of Androgenetic Alopecia in Females
In Brief
A clinical study evaluating HairMax LaserComb 2009 model 12 beam and Sham Device for Androgenetic Alopecia and 2 related conditions. Completed, enrolled 63 participants across 3 sites.
Detailed Summary
The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 12 beam model for androgenetic alopecia in females when treatment is applied as directed.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAndrogenetic Alopecia, Hair Loss, Female Pattern Baldness
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 2009
Enrollment StartJan 2010
Primary CompletionMar 2011
TodayJul 2026
First PostedNov 20, 2009
Enrollment StartJan 1, 2010
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 16.6 years ago
Interventions
HairMax LaserComb 2009 model 12 beamdevice
HairMax LaserComb
Sham Devicedevice
Sham Device